227 verified investors — including the ones outside Canada who fund Canadian companies — and 101 non-dilutive programs with the fine print that determines fit. We turn them into a sequenced plan for your exact stage, sector, and province.
Not investor-ready yet? Save hours of research time by starting with a simple, curated list of non-dilutive funding sources. This is the first step to building your funding roadmap.
Start here if you're not ready for $99 yet. Upgrade to the full Roadmap within 60 days for $59.
Start →
Your sequenced funding roadmap: grants to file now plus the investors who fit your exact stage (minus ones you've pitched). Bonus: email outreach template and subscription to The On-Ramp for monthly application deadlines for incubators, accelerators, and pitch competitions.
Includes everything in the Non-Dilutive Sprint. Choose one or the other, not both.
Start my Roadmap →
Everything in the Capital Roadmap, plus 30 minutes with Landon Steele — founder, operator, investor — on your specific situation.
You'll book your call right after checkout.
Start →
This is page one of a complete 4-page Capital Roadmap for a fictional Halifax medical-device founder — but every investor, program, and deadline in it is real and verified. Sequenced NOW / NEXT / LATER, with the outreach templates and the guarantee in writing.
Want the whole thing? We'll email you the full sample (plus the $49 Non-Dilutive Sprint sample) when you subscribe to The On-Ramp — our free monthly deadline digest.
Get the full sample PDF →Checkout takes a minute; the intake form takes five. Stage, sector, province, how much you're raising, and who you've already pitched — that last list matters, it's what your guarantee is measured against.
A human matches you against the verified database — every profile checked against public sources and date-stamped. No auto-generated lists, no stale directories.
Your Roadmap lands in your inbox: non-dilutive first, then investors sequenced by stage, with outreach templates and next deadlines. Questions? Reply to the delivery email.
Early-stage healthcare, health tech, medical device, pharma/biotech, and life science companies based in Canada, raising from first cheque through Series A. That's deliberate: verified depth in one sector beats shallow coverage of every sector. If you're a Canadian health founder, this database was built for you. If you're a fintech in Austin, not yet. The beachhead expands later.
Companies outside healthcare and life sciences, companies not incorporated or operating in Canada, and companies past Series A. We'd rather tell you now than take your $99 and deliver a thin roadmap. That's what the guarantee is for, but better you never need it.
The Non-Dilutive Sprint ($49): a curated list of grants, tax credits, and programs matched to your stage, focus, and province, with the fine print that matters (reimbursement vs. up-front, matching requirements). The Capital Roadmap ($99): everything above plus the investors who fit your exact stage and sector, minus everyone you've already pitched, sequenced NOW / NEXT / LATER with outreach templates. The $249 tier adds 30 minutes with Landon Steele. Sprint buyers can upgrade to the full Roadmap within 60 days for $59.
Three ways. Every profile is verified by a human and date-stamped: no dead funds, no stale theses. It's subtractive: your roadmap removes investors you've already pitched, so every name is actionable. And it includes the category nobody else maintains: investors outside Canada who fund Canadian companies.
Start with fit, not volume. Canada has active health-focused angel groups — HaloHealth's 400+ physician investors among them, plus regional networks in nearly every province — and foreign angels who fund Canadian companies. Read the full answer →
More than most founders realize: SR&ED tax credits (up to ~35% refundable for CCPCs), NRC IRAP contributions, Mitacs internship funding, Innovative Solutions Canada, and provincial programs from Genome BC to Ontario's FACIT. What separates the useful from the theoretical is when the cash actually arrives. Read the full answer →
Yes, and more do than founders assume. Some US funds are Canada-dedicated (Maple VC), some run Canadian offices (Versant Ventures in Vancouver), and several US angel groups state no geographic restriction at all. The catch: nobody maintains a list of them. Read the full answer →
Sequence both, and start the non-dilutive paperwork first: it costs no equity and strengthens your investor story. But know the trap — SR&ED, IRAP and Mitacs reimburse or match, so you need cash before their money arrives. Read the full answer →
Accelerators run fixed-length cohorts with application deadlines, mentorship, and often funding or prizes. Incubators are open-ended: space, mentorship and network, usually without direct funding. Both matter at different moments. Read the full answer →
It means your traction matches what investors at your target round expect to see, and that bar differs by sector and stage. Traction alone is not the whole bar — you also need a story that explains why it matters. Read the full answer →
Your regulatory pathway is the single biggest filter on which investors can fund you, because it decides how long and how expensive the road to market is. A Class IV implant founder and a wellness-app founder are both “health,” and their usable investor lists barely overlap. Read the full answer →
Mostly yes. Y Combinator accepts Canadian corporations (confirmed, after reversing its brief 2026 pause), MedTech Innovator is fully virtual with no fee and no equity, and MassChallenge accepts global applicants. Read the full answer →
Within 2 business days of completing your intake. Built by a human against the verified database, not auto-generated.
Every Capital Roadmap surfaces at least 5 qualified investors not on the already-pitched list you give us at intake, or we refund it in full. Email your order number and reason to guarantee@mycapitalroadmap.com; we respond within 2 business days.
Never and never. Investors don't pay for placement, sponsors don't influence listings, and we don't sell intros. Where an organization charges founders to pitch, we say so loudly on the listing. That's our flagging policy, not a business model.
Yes. That's exactly when the sequencing matters most. Most pre-revenue founders start with the Non-Dilutive Sprint (money that costs no equity), then upgrade when they're investor-ready.
It's used to build your roadmap, nothing else. We don't sell it, share it, or add you to lists you didn't opt into. The On-Ramp newsletter is opt-in only. Full details on our Terms & Privacy page.
We don't accept sponsorships from investors, accelerators, or incubators; the listings stay independent, and that isn't for sale. Everyone else (startup law firms, SR&ED advisors, banks, service providers to founders) is welcome to reach out: hello@mycapitalroadmap.com.
The $249 tier includes 30 minutes with Landon Steele, and that's the right start for most founders. If you need more than a call (investment-readiness work, fundraising strategy, ongoing guidance), that's Steele Consulting Group. Reach out to landon@steeleconsultinggroup.com to discuss a deeper consulting relationship.
Every accelerator, incubator, and pitch competition deadline that matters to Canadian health founders, in one monthly email. No more last-minute application all-nighters.
86 programs and competitions tracked — funded ones marked so you can tell at a glance.
This map is crowdsource-assisted and human-verified: suggestions are researched and reviewed before anything goes live. We're especially hunting investors outside Canada who fund Canadian companies — the list nobody else maintains. Three fields, thirty seconds.
Investors, programs, competitions, accelerators, family offices — one form covers them all. Stale deadline, changed thesis, broken link? Same door: we fix it fast.
My Capital Roadmap